In a regulatory filing, Elevance Health (ELV) noted it will release its first quarter 2025 financial results on April 22. “First quarter results reflect medical cost trends that developed in line with the company’s expectations, including in its Medicare Advantage business. While cost trends in Medicare Advantage remain elevated, the company’s first quarter experience was consistent with its expectations and pricing. In addition, the company continues to expect full-year 2025 Medicare Advantage membership of 2,200 to 2,250 thousand members, in line with the guidance provided in its Fourth Quarter 2024 Earnings Release, dated January 23, 2025. Based on these results and the company’s outlook, the company intends to reaffirm shareholders’ adjusted net income guidance for full year 2025 to be $34.15 to $34.85 per diluted share. The company will provide additional details on its first quarter financial results and full year outlook when it reports results on April 22,” the filing stated.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELV:
- Elevance Health sees Q1 adjusted EPS $11.97, consensus $11.38
- Morgan Stanley expects UnitedHealth shares to fall following guidance cut
- Nike initiated, GM downgraded: Wall Street’s top analyst calls
- Elevance Health price target raised to $428 from $405 at Morgan Stanley
- Elevance Health downgraded to Neutral from Outperform at Baird